eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | neutropenia |
| Comorbidity | C0149925|small cell lung cancer |
| Sentences | 3 |
| PubMedID- 20644495 | Background: previous studies investigating the effect of increased dose intensity and chemotherapy-induced neutropenia in patients with advanced non-small cell lung cancer (nsclc) have not consistently shown significant survival benefits. |
| PubMedID- 23489558 | Clinicians should be aware that gefitinib-induced neutropenia in patients with non-small cell lung cancer can be treated successful by switching to erlotinib. |
| PubMedID- 22133387 | The highest incidence of severe neutropenia was found in patients with non-small cell lung cancer (61%; 95% ci 50, 74), while the lowest incidence was seen in patients with squamous cell carcinoma of the esophagus (22%; 95% ci 11, 45). |
Page: 1